Kim Susan G.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$1.02M

Insider Activity of Kim Susan G.

According to the SEC Form 4 filings, Kim Susan G., being in a position of

  1. See Remarks at Pacific Biosciences of California, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 48384 shares for $198,162,
    over all time since 2021-09-29, has bought 0 shares, and sold 107895 shares for $1.02M.

The largest sale of all time was on 2021-09-29 and amounted to 20272 shares of Pacific Biosciences of California, Inc. for $522,004.

Biography of Kim Susan G.

No biography is available at this moment.

2024-09-30SalePacific Biosciences of California, Inc.
PACB
See Remarks
19,782
0.0072%
$1.72$34,065-3.82%
2024-03-04SalePacific Biosciences of California, Inc.
PACB
See Remarks
5,275
0.002%
$4.87$25,695-62.7%
2024-02-20SalePacific Biosciences of California, Inc.
PACB
See Remarks
831
0.0003%
$5.26$4,372-65.03%
2024-02-16SalePacific Biosciences of California, Inc.
PACB
See Remarks
22,496
0.0087%
$5.96$134,031-67.77%
2023-09-29SalePacific Biosciences of California, Inc.
PACB
See Remarks
19,257
0.0078%
$8.44$162,471-52.63%
2023-03-03SalePacific Biosciences of California, Inc.
PACB
See Remarks
5,045
0.002%
$9.49$47,892-0.81%
2023-02-17SalePacific Biosciences of California, Inc.
PACB
See Remarks
907
0.0004%
$10.27$9,316-6.08%
2022-09-29SalePacific Biosciences of California, Inc.
PACB
See Remarks
12,968
0.0058%
$5.61$72,802+90.09%
2022-02-17SalePacific Biosciences of California, Inc.
PACB
Chief Financial Officer
1,062
0.0005%
$11.06$11,746-31.64%
2021-09-29SalePacific Biosciences of California, Inc.
PACB
Chief Financial Officer
20,272
0.0104%
$25.75$522,004-62.47%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.